Sanderling has supported over 90 biomedical companies earning consistently high rates of return on its venture investments.
Investment Type: Venture Capital
Mentions in press and media 19
| Date | Title | Description | Source |
| 26.11.2016 | Chiesi Ventures Joins $12M Series A for Glycomine | Glycomine, Inc. a biotechnology company developing a new generation of replacement therapies for rar... | citybizlis... |
| 10.10.2013 | No catheter, no cuff: FDA clears Sotera Wireless’ continuous... | The ViSi Mobile System, a wrist-worn monitor that measures vital signs and is designed to be used in... | medcitynew... |
| 05.09.2013 | BDC and FTQ Pour Major Investment into New Montreal Biomedic... | Money seems to be flying around Montreal these days. The Business Development Bank of Canada (BDC) ... | betakit.co... |
| 13.12.2011 | Sotera Wireless Completes $12.2M Series D Financing | Sotera Wireless, Inc., a San Diego CA-based medical device company, completed a $12.2m Series D fina... | finsmes.co... |
| 18.08.2010 | Cancer drug developer Endocyte files for $86M IPO | Endocyte’s small-molecule drug conjugates “actively target receptors that are over-expressed on dise... | medcitynew... |
| 04.08.2010 | Cancer drugmaker Gemin X closes $8M Series E round | It’s unclear when Gemin X will begin its Phase 3 trial, but it’s safe to say it won’t happen this ye... | medcitynew... |
| 07.04.2010 | Torax Medical wins CE Mark for GERD device | By Brandon Glenn Torax Medical Inc. won CE Mark approval in the European Union for an implantable d... | massdevice... |
| 07.04.2010 | Torax Medical gets European OK for acid reflux disease devic... | The device has not yet been cleared for U.S. sales. In September, Torax completed patient enrollment... | medcitynew... |
| 16.10.2009 | Cancer drug business Endocyte raises $26 million | Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis... | medcitynew... |
| 16.04.2008 | Xytis gets $7.5M to work on central nervous system disorders | Xytis, a privately-held biotech company based in both the U.S. (Irvine, CA) and Europe (London, Engl... | venturebea... |
Show more